Menu
A phase IIb, double-blind, randomised, placebo-controlled trial to evaluate the efficacy and tolerability of ZED1227 in celiac disease subjects experiencing symptoms despite gluten-free diet.
To assess 3 different doses and 2 different dosing schedules of ZED1227 capsules for efficacy in: improving duodenal mucosal and coeliac disease symptoms subjects experiencing symptoms and having mucosal damage despite gluten-free diet.
.
You may be eligible for the study if you meet the following criteria.
Please contact CDH Research Institute on 07 5408 0900 for additional information or use the email link below. You can also share details of this study to social media via the links below?
Clinical trials are important because they serve as the foundation for most medical advances.
